NCT05923489Recruiting
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients (The REVISE Trial)
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 2618 (estimated)
- First submitted
- 20 Jun 2023
- Start date
- 26 Oct 2023
- Primary completion date
- 30 Dec 2028
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Coronary artery disease
- NCT number
- NCT05923489
What you commit to
- Study type: Interventional
- Planned participants: 2618
- From 26 Oct 2023 to the primary completion date, 30 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Revascularization with bare metal stents and/or balloon angioplasty with non-drug-coated balloons.
- Repeat interventional therapy is planned.
Other
- Pregnant and/or lactating women.
- Life expectancy of less than 2 years.
- Subject was unable to provide written informed consent.
Who the study is looking for
- Age ≥ 18 years.
- Successful PCI with at least two of the following high-risk factors:
- Left main lesion; B. Bifurcation lesion (true bifurcation); C. Ostial lesion of main vessels (left anterior descending, left circumflex artery, right coronary artery); D. Chronic total occlusion; E. Multivessel revascularization (≥ 2 vessels); F. In-stent restenosis; G. Diffuse long lesion (lesion length ≥ 30 mm or stent length ≥ 38 mm); H. Severe calcified lesion (Significant severe calcification on angiography); I. Bypass graft lesion; J. Diabetes mellitus; K. Chronic kidney disease (defined as an estimated glomerular filtration rate of \<30 ml per minute per 1.73 m2 of body-surface area or the receipt of dialysis); L. Myocardial infarction;
- \- He/she or his/her legally authorized representative provides written informed
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Second Affiliated Hospital of Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.